Skip to main content
Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
9.48
+0.52 (5.80%)
Nov 15, 2024, 3:15 PM EST - Market open

Teladoc Health Revenue by Segment
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Access Fees Revenue
2.25B 2.27B 2.29B 2.28B 2.26B 2.22B 2.16B 2.10B
Access Fees Revenue Growth
-0.72% 2.37% 5.80% 8.49% 11.50% 14.42% 16.57% 20.46%
Other Revenue
343.59M 336.53M 330.48M 319.89M 317.33M 244.92M 175.09M 102.80M
Other Revenue Growth
8.28% 37.40% 88.75% 211.18% 865.70% 558.40% 337.15% 128.32%

Operating Metrics

Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
US Integrated Care Members
93.90M 92.40M 91.80M 89.60M 90.20M 85.90M 84.90M 83.30M - - - - - - - - - - - - - - - - - - -
US Integrated Care Members Growth
4.10% 7.57% 8.13% 7.56% 10.13% - - - - - - - - - - - - - - - - - - - - - -
Visits
17.80M 18.10M 18.10M 18.40M 18.80M 18.97M 18.93M 18.54M
Visits Growth
-5.32% -4.60% -4.39% -0.77% 3.59% 7.96% 14.28% 20.41%
Chronic Care Enrollment
1.18M 1.17M 1.12M 1.16M 1.12M 1.07M 1.03M 1.02M - - - - - - - - - - - - - - - - - - -
Chronic Care Enrollment Growth
5.08% 9.32% 9.05% 13.64% 12.99% - - - - - - - - - - - - - - - - - - - - - -
BetterHelp Paying Users
398.00K 407.00K 415.00K 425.00K 459.00K 476.00K 467.00K 450.00K - - - - - - - - - - - - - - - - - - -
BetterHelp Paying Users Growth
-13.29% -14.50% -11.13% -5.56% 5.03% - - - - - - - - - - - - - - - - - - - - - -

Revenue by Geography
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021
US Revenue
2.19B 2.22B 2.24B 2.24B 2.23B 2.19B 2.15B 2.10B
US Revenue Growth
-1.71% 1.38% 4.28% 6.50% 9.76% 12.36% 15.07% 18.44%
International Revenue
400.28M 386.85M 376.21M 365.26M 352.79M 339.26M 319.26M 305.83M
International Revenue Growth
13.46% 14.03% 17.84% 19.43% 20.05% 20.09% 16.30% 18.22%

Operating Expense Breakdown
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
Marketing
678.22M 686.91M 695.39M 688.85M 688.14M 680.91M 666.73M 623.54M
Marketing Growth
-1.44% 0.88% 4.30% 10.48% 16.62% 30.38% 44.66% 49.63%
General and Administrative
444.45M 445.92M 462.21M 464.66M 475.55M 472.37M 457.40M 448.18M
General and Administrative Growth
-6.54% -5.60% 1.05% 3.68% 6.40% 7.99% 4.49% 2.32%
Depreciation and Amortization
381.55M 386.28M 365.18M 337.07M 315.27M 282.97M 266.88M 256.03M
Depreciation and Amortization Growth
21.02% 36.51% 36.83% 31.65% 35.51% 27.15% 24.41% 25.36%
Research and Development
320.46M 332.37M 342.92M 348.52M 341.51M 345.04M 338.56M 338.98M
Research and Development Growth
-6.16% -3.67% 1.29% 2.81% 3.83% 7.37% 5.37% 8.69%
Sales
205.72M 210.56M 213.65M 213.78M 216.61M 218.93M 223.33M 227.17M
Sales Growth
-5.03% -3.82% -4.33% -5.89% -5.91% -8.09% -8.51% -9.34%
Acquisition and Integration
5.95M 11.32M 15.94M 21.51M 23.48M 19.25M 17.06M 15.62M
Acquisition and Integration Growth
-74.66% -41.20% -6.55% 37.71% 73.22% 18.08% -31.30% -41.37%
Goodwill Impairment
- - - - - - - 13.40B
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.